TrialThe Journal of antimicrobial chemotherapy2022

Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection.

Ed J Gane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.